EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alhagi honey polysaccharide ameliorates carbon tetrachloride-induced liver fibrosis via modulating the gut microbiota-liver metabolism axis

Jianzhong Song, Xin Zhao, Lingling Cao, Yingying Chen, Xingchen Zhou, Jinfa Li, Peijin You, Jing Zhou, Zhiyuan Lv, Xiumin Ma, Junmin Chang

Frontiers in Nutrition · 28.05.2026 · 13

DOI: 10.3389/fnut.2026.1862546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 28.05.2026. Verfasst von Jianzhong Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: Postdoctoral Research Workstation of Tumor Hospital affiliated to Xinjiang Medical University, Urumqi, China. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver fibrosis (LF) is a progressive injury that frequently advances to cirrhosis and hepatocellular carcinoma, yet effective intervention strategies remain limited. Alhagi honey polysaccharide (AHPN), a bioactive macromolecule with a molecular weight of 9.35 × 10ł Da primarily composed of mannose (29.384%), glucose (41.804%), and galactose (28.810%), represents a promising candidate for antifibrotic therapy.

Methods

This study established a carbon tetrachloride (CCl 4 )-induced liver fibrosis mouse model to evaluate AHPN’s intervention effect. Liver injury, collagen deposition, and fibrosis progression were assessed histologically and biochemically. The underlying mechanisms were explored through analysis of the TGF-β1/Smad3 signaling pathway, hepatic stellate cell activation, Nrf2/HO-1 antioxidant pathway, inflammatory cytokine profiles, and fibrosis marker expression. Additionally, 16S rDNA sequencing and metabolomics were employed to investigate AHPN’s regulatory effects on gut microbiota composition and hepatic metabolism.

Results

AHPN administration significantly attenuated hepatic injury, reduced collagen deposition, and suppressed fibrosis progression by inhibiting TGF-β1/Smad3 signaling and hepatic stellate cell activation, accompanied by restored liver function. Mechanistically, AHPN activated the Nrf2/HO-1 pathway to alleviate oxidative stress, decreased serum levels of pro-inflammatory cytokines (IL-6, IL-1β, TNF-α), and downregulated fibrosis-related markers (α-SMA, collagen I, LN, PCIII, IV-C). Notably, 16S rDNA sequencing revealed that AHPN enriched beneficial gut bacteria including Bacteroidaceae , Lactobacillaceae , and Marinifilaceae while restoring intestinal tight junction proteins (Occludin, ZO-1). Metabolomics analysis further demonstrated that AHPN improved hepatic metabolic disorders.

Conclusion

These findings indicate that AHPN ameliorates CCl 4 -induced liver fibrosis through a multi-targeted mechanism involving suppression of TGF-β1/Smad3 signaling, activation of the Nrf2/HO-1 antioxidant pathway, reduction of inflammatory responses, and crucially, modulation of the gut microbiota-liver metabolism axis. These findings underscore the potential of dietary polysaccharides in modulating the gut microbiota-liver metabolism axis and provide a basis for developing nutritional strategies against liver fibrosis.

Schlagwörter

Stichwörter der Autor:innen

Alhagi honey polysaccharidegut microbiota-liver metabolism axisintestinal barrierliver fibrosisoxidative stress

Autor:innen und Institutionen

  • Postdoctoral Research Workstation of Tumor Hospital affiliated to Xinjiang Medical University, Urumqi, China.
  • Department of Pharmacy, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi, China.
  • Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
  • Xinjiang Cardiovascular and Cerebrovascular Disease Hospital Laboratory Department, Urumqi, Xinjiang, China.
  • Department of Pharmacy, Baiyin Hospital of Integrated Traditional Chinese and Western Medicine, Gansu, China.
  • Division of (Bio) Pharmaceutics, Institute of Zhejiang University-Quzhou, Quzhou, China.

Zitieren

APA

Song, J., Zhao, X., Cao, L., Chen, Y., Zhou, X., Li, J., You, P., Zhou, J., Lv, Z., Ma, X., & Chang, J. (2026). Alhagi honey polysaccharide ameliorates carbon tetrachloride-induced liver fibrosis via modulating the gut microbiota-liver metabolism axis. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1862546

Vancouver

Song J, Zhao X, Cao L, Chen Y, Zhou X, Li J, et al. Alhagi honey polysaccharide ameliorates carbon tetrachloride-induced liver fibrosis via modulating the gut microbiota-liver metabolism axis. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1862546

BibTeX
@article{Song2026,
  author = {Song, Jianzhong and Zhao, Xin and Cao, Lingling and Chen, Yingying and Zhou, Xingchen and Li, Jinfa and You, Peijin and Zhou, Jing and Lv, Zhiyuan and Ma, Xiumin and Chang, Junmin},
  title = {Alhagi honey polysaccharide ameliorates carbon tetrachloride-induced liver fibrosis via modulating the gut microbiota-liver metabolism axis},
  journal = {Frontiers in Nutrition},
  year = {2026},
  volume = {13},
  doi = {10.3389/fnut.2026.1862546}
}
Kostenlos starten →